Literature DB >> 10552109

Informed consent in surgical trials.

E Etchells1.   

Abstract

All participants must provide a valid consent to surgical clinical trials. A valid consent requires patient capacity, adequate disclosure of information, and voluntariness. Capacity is the ability to understand information relevant to making a decision and to appreciate the reasonably foreseeable consequences of a decision or lack of decision. To protect vulnerable persons, an incapable person should not be enrolled in most clinical trials. The only exception is if the study can only be conducted on incapable persons. If the willing research participant is incapable, consent must be obtained from others through a process called substitute (or proxy) consent. Disclosure refers to the provision of relevant information to the patient and its comprehension by the patient. Most surgical trials carry more than minimal risks, so the requirement for careful disclosure of these risks to potential participants is generally stringent. Voluntariness refers to the freedom of a person to make a treatment decision. In specific circumstances related to emergency research, the requirement for consent may be waived. Waiver can be justified only if the delay required to obtain consent would prevent the research from occurring and only after prior consultation with from the "community" of potential research participants.

Entities:  

Mesh:

Year:  1999        PMID: 10552109     DOI: 10.1007/s002689900650

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  10 in total

1.  Assessing the bioethical integrity of a clinical trial in surgery.

Authors:  Mark Bernstein
Journal:  Can J Surg       Date:  2004-10       Impact factor: 2.089

2.  Fully informed consent is impossible in surgical clinical trials.

Authors:  Mark Bernstein
Journal:  Can J Surg       Date:  2005-08       Impact factor: 2.089

Review 3.  Designing randomized clinical trials in pediatric neurosurgery.

Authors:  Peter Kan; John R W Kestle
Journal:  Childs Nerv Syst       Date:  2007-02-06       Impact factor: 1.475

4.  Long-term results of laparoscopic versus open colorectal resections for cancer in 235 patients with a minimum follow-up of 5 years.

Authors:  E Lezoche; M Guerrieri; A De Sanctis; R Campagnacci; M Baldarelli; G Lezoche; A M Paganini
Journal:  Surg Endosc       Date:  2006-02-27       Impact factor: 4.584

5.  Patients' perception of the informed consent process for neurooncology clinical trials.

Authors:  Eva Knifed; Nir Lipsman; Warren Mason; Mark Bernstein
Journal:  Neuro Oncol       Date:  2008-04-03       Impact factor: 12.300

6.  Laparoscopic versus open colectomy for TNM stage III colon cancer: results of a prospective multicenter study in Italy.

Authors:  Mario Guerrieri; Roberto Campagnacci; Angelo De Sanctis; Giovanni Lezoche; Paolo Massucco; Massimo Summa; Rosaria Gesuita; Lorenzo Capussotti; Giuseppe Spinoglio; Emanuele Lezoche
Journal:  Surg Today       Date:  2012-08-19       Impact factor: 2.549

7.  From the patient's perspective: is there a need to improve the quality of informed consent for surgery in training hospitals?

Authors:  Shamir O Cawich; Alan T Barnett; Ivor W Crandon; Samantha D Drew; Georgiana Gordon-Strachan
Journal:  Perm J       Date:  2013

Review 8.  Challenges of conducting multi-center, multi-disciplinary urinary incontinence clinical trials: experience of the urinary incontinence treatment network.

Authors:  William Steers; Holly Richter; Leroy Nyberg; John Kusek; Stephen Kraus; Kimberly Dandreo; Toby Chai; Linda Brubaker
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

9.  Extended preoperative patient education using a multimedia DVD-impact on patients receiving a laparoscopic cholecystectomy: a randomised controlled trial.

Authors:  D Wilhelm; S Gillen; H Wirnhier; M Kranzfelder; A Schneider; A Schmidt; H Friess; H Feussner
Journal:  Langenbecks Arch Surg       Date:  2009-01-17       Impact factor: 3.445

10.  Ethical guideposts to clinical trials in oncology.

Authors:  M Bernstein
Journal:  Curr Oncol       Date:  2006-04       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.